BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24618618)

  • 1. Nullifying the CDKN2AB locus promotes mutant K-ras lung tumorigenesis.
    Schuster K; Venkateswaran N; Rabellino A; Girard L; Peña-Llopis S; Scaglioni PP
    Mol Cancer Res; 2014 Jun; 12(6):912-23. PubMed ID: 24618618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer.
    Gamell C; Gulati T; Levav-Cohen Y; Young RJ; Do H; Pilling P; Takano E; Watkins N; Fox SB; Russell P; Ginsberg D; Monahan BJ; Wright G; Dobrovic A; Haupt S; Solomon B; Haupt Y
    Sci Signal; 2017 Jan; 10(461):. PubMed ID: 28074012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.
    Krimpenfort P; Ijpenberg A; Song JY; van der Valk M; Nawijn M; Zevenhoven J; Berns A
    Nature; 2007 Aug; 448(7156):943-6. PubMed ID: 17713536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
    Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RHOA-FAK is a required signaling axis for the maintenance of KRAS-driven lung adenocarcinomas.
    Konstantinidou G; Ramadori G; Torti F; Kangasniemi K; Ramirez RE; Cai Y; Behrens C; Dellinger MT; Brekken RA; Wistuba II; Heguy A; Teruya-Feldstein J; Scaglioni PP
    Cancer Discov; 2013 Apr; 3(4):444-57. PubMed ID: 23358651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
    Wang Y; Zhang Z; Kastens E; Lubet RA; You M
    Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
    Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
    Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LKB1 modulates lung cancer differentiation and metastasis.
    Ji H; Ramsey MR; Hayes DN; Fan C; McNamara K; Kozlowski P; Torrice C; Wu MC; Shimamura T; Perera SA; Liang MC; Cai D; Naumov GN; Bao L; Contreras CM; Li D; Chen L; Krishnamurthy J; Koivunen J; Chirieac LR; Padera RF; Bronson RT; Lindeman NI; Christiani DC; Lin X; Shapiro GI; Jänne PA; Johnson BE; Meyerson M; Kwiatkowski DJ; Castrillon DH; Bardeesy N; Sharpless NE; Wong KK
    Nature; 2007 Aug; 448(7155):807-10. PubMed ID: 17676035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer.
    Tam KW; Zhang W; Soh J; Stastny V; Chen M; Sun H; Thu K; Rios JJ; Yang C; Marconett CN; Selamat SA; Laird-Offringa IA; Taguchi A; Hanash S; Shames D; Ma X; Zhang MQ; Lam WL; Gazdar A
    J Thorac Oncol; 2013 Nov; 8(11):1378-88. PubMed ID: 24077454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A.
    Tu Q; Hao J; Zhou X; Yan L; Dai H; Sun B; Yang D; An S; Lv L; Jiao B; Chen C; Lai R; Shi P; Zhao X
    Oncogene; 2018 Jan; 37(1):128-138. PubMed ID: 28892048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer.
    Mallakin A; Sugiyama T; Taneja P; Matise LA; Frazier DP; Choudhary M; Hawkins GA; D'Agostino RB; Willingham MC; Inoue K
    Cancer Cell; 2007 Oct; 12(4):381-94. PubMed ID: 17936562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma.
    Busch SE; Moser RD; Gurley KE; Kelly-Spratt KS; Liggitt HD; Kemp CJ
    Oncogene; 2014 May; 33(20):2665-73. PubMed ID: 23752194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
    Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
    Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma.
    McFadden DG; Politi K; Bhutkar A; Chen FK; Song X; Pirun M; Santiago PM; Kim-Kiselak C; Platt JT; Lee E; Hodges E; Rosebrock AP; Bronson RT; Socci ND; Hannon GJ; Jacks T; Varmus H
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6409-E6417. PubMed ID: 27702896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
    Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer.
    Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D
    Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis.
    Altomare DA; Menges CW; Xu J; Pei J; Zhang L; Tadevosyan A; Neumann-Domer E; Liu Z; Carbone M; Chudoba I; Klein-Szanto AJ; Testa JR
    PLoS One; 2011 Apr; 6(4):e18828. PubMed ID: 21526190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.